beta
(영문) 대전지방법원 2015.07.01 2012가합34928

손해배상(의)

Text

1. The Defendant shall start on May 4, 201 with respect to the Plaintiff A’s KRW 10,000,000, KRW 5,000,000, and each of the above amounts.

Reasons

1. The following facts may be found in full view of Gap evidence Nos. 1 through 10, Eul evidence Nos. 2 through 6, the results of a request for appraisal of medical records to the Korean Medical Association, and the purport of all pleadings:

A Party Status C (hereinafter referred to as “the deceased”) is a patient who died on May 4, 201 when the Defendant received medical treatment at the Chungcheongnamnam University Hospital (hereinafter “Defendant Hospital”) operated by the Defendant, and the Plaintiff A inherited the deceased as the husband of the deceased, and the Plaintiff B inherited the deceased as the deceased’s children:

B. On May 22, 2007, the Deceased’s diagnosis and treatment, medication, and death (1) The Deceased performed a marine surgery at the Synas Hospital on cerebral mathy, and thereafter on June 2009, he/she was under the surgery at the Synas Hospital, and he/she was under the surgery at the Defendant Hospital’s Mamera D, etc. (hereinafter “Defendant Hospital Medical Center”).

(B) Around 2010, the administration was suspended, on the basis of the ex-postary treatment, with regard to the ex-postary symptoms, such as negopathy, and on the basis of the ex-postary treatment.

As the Deceased complained for an increase in the weight of body, which is the side effect of the protoo, the medical personnel at the Defendant Hospital started to reduce the number of protoo and to administer the protopy instead of it. 2) After the administration of the said protopy pin, the Deceased was hospitalized immediately after around March 5, 201, and was in an emergency room at the Defendant hospital, claiming for the skin safin, the skin safin, the hair safin, and the safin was diagnosed on March 6, 2011, as the deceased complained of an increase in the weight of body, which is the side effect of the protoo.

3) After the Deceased’s hospitalization, the Defendant hospital suspended the scarbine medication, and performed the scard treatment to treat the various symptoms infected by the scarbine scard. On April 15, 2011, the deceased was discharged upon the scard treatment, and continued to observe the progress through scard treatment. 4) The Deceased was discharged after discharge.